Skip to main content

Vietnam Pharmaceuticals Market Report 2022: Formidable Growth Driven by Increased Healthcare Infrastructure -

The "Vietnam Pharmaceuticals Market, By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2017-2027" report has been added to's offering.

Vietnam pharmaceuticals market is anticipated to grow at a formidable rate during the forecast period. The market growth can be attributed to the rising development of medicinal drugs and pharmaceutical products and the growing healthcare infrastructure in the country.

Consistent research and drug discovery for the development and production of active pharmaceutical ingredients and increased investments by market players for the marketing of branded and generic pharmaceuticals are some of the factors aiding the growth of the Vietnam pharmaceuticals market. The increasing geriatric population and sedentary lifestyles leading to increased chronic disorders are contributing to the growth of the Vietnam pharmaceuticals market.

High urban pollution levels are increasing incidences of respiratory diseases such as asthma, and the growing consumption of pharmaceutical drugs such as cholesterol-lowering drugs, anti-depressants, anti-hypersensitive, and anti-diabetic drugs are some of the factors anticipated to drive the Vietnam pharmaceuticals market.

An upsurge in infectious disorders such as acquired immunodeficiency syndrome, malaria, tuberculosis, etc., among the population in the country and increased efforts by the pharmaceutical companies to develop new chemical and biological entities to generate more effective vaccines are also adding to the growth of the Vietnam pharmaceuticals market. Besides, rapidly growing eCommerce channels in the country providing pharmaceutical products at affordable rates and within the convenience of consumers' homes are driving the growth of the Vietnam pharmaceuticals market.

Objective of the Study:

  • To analyze the historical growth in the market size of Vietnam pharmaceuticals market from 2017 to 2021.
  • To estimate and forecast the market size of Vietnam pharmaceuticals market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast Vietnam pharmaceuticals market based on drug type, product type, application, distribution channel, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the Vietnam pharmaceuticals market.
  • To identify drivers and challenges for Vietnam pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in Vietnam pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in Vietnam pharmaceuticals market.
  • To identify key sustainable strategies adopted by market players in Vietnam pharmaceuticals market

Report Scope:

In this report, Vietnam pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Vietnam Pharmaceuticals Market, By Drug Type:

  • Generic Drugs
  • Branded Drugs

Vietnam Pharmaceuticals Market, By Product Type:

  • Prescription Drugs
  • Over-The-Counter Drugs

Vietnam Pharmaceuticals Market, By Application:

  • Cardiovascular
  • Musculoskeletal
  • Oncology
  • Anti-infective
  • Metabolic Disorder
  • Others

Vietnam Pharmaceuticals Market, By Distribution Channel:

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-Pharmacy

Vietnam Pharmaceuticals Market, By Region:

  • Northern
  • Central
  • Southern

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Vietnam Pharmaceuticals Market

5. Voice of Customers

6. Vietnam Pharmaceuticals Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Drug Type (Generic Drugs v/s Branded Drugs)

6.2.2. By Product Type (Prescription Drugs v/s Over-The-Counter Drugs)

6.2.3. By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others)

6.2.4. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)

6.2.5. By Region

6.2.6. By Company (2021)

6.3. Product Market Map

7. Vietnam Generic Drugs Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Application

7.2.3. By Distribution Channel

8. Vietnam Branded Drugs Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Application

8.2.3. By Distribution Channel

9. Market Dynamics

9.1. Drivers

9.2. Challenges

10. Market Trends & Developments

11. Policy & Regulatory Landscape

12. Vietnam Economic Profile

13. Competitive Landscape

14. Strategic Recommendations

Companies Mentioned

  • DHG Pharmaceutical Joint Stock Company
  • Traphaco Joint Stock Company
  • Pymepharco Joint Stock Company
  • Hatay Pharmaceutical Joint Stock Company
  • Mekophar Chemical Pharmaceutical JSC
  • Imexpharm Corporation
  • OPC Pharmaceutical Joint Stock Company

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.